Law firm Lifshitz, PC announces investigations into



NEW YORK, December 23, 2021 (GLOBE NEWSWIRE) –

Bristol-Myers Squibb Company (NYSE: BMY)

Lifshitz Law Firm, PC announces that a class action lawsuit has been filed against BMY alleging that the proxy statement contained materially false and misleading representations which caused the plaintiffs and other class members to accept merger consideration which failed to adequately value the shares of Celgene, and that as a result of their possession and exchange of Celgene common shares in connection with the Merger, the Plaintiffs and other Class members suffered a loss economic.

If you are a BMY investor and would like additional information about our investigation, please complete the information request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]

Hyzon Motors Inc. (NASDAQ: HYZN)

Lifshitz Law Firm, PC announces that a class action lawsuit has been filed against Hyzon alleging that the Defendants throughout the Class Period made false and / or misleading statements and / or failed to disclose that: (1) Hyzon distorted the nature of his “client” contracts and severely embellished his “deals” and “partnerships” with clients; (2) Hyzon was unable to deliver its vehicles announced in 2021, within the announced deadlines; and (3) accordingly, the defendants’ public statements were materially false and / or misleading at all material times.

If you are a Hyzon investor and would like additional information about our investigation, please complete the Information Request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]

Nano-X Imaging Ltd. (NASDAQ: NNOX)

Lifshitz Law Firm, PC announces that a class action lawsuit has been filed against Nano-X alleging that the defendants made false and / or misleading statements and / or failed to disclose that: (i) Nano’s trade agreements -X and its clients were fabricated; (ii) Nano-X’s statements regarding its “new” Nanox system were misleading, as the Company never provided any data comparing its images with images of competing machines; (iii) the submission of Nano-X to the United States Food and Drug Administration (“FDA”) admitted that the Nanox system was not original; and (iv) accordingly, the defendants’ public statements were materially false and / or misleading at all relevant times.

If you are a Nano-X investor and would like additional information about our survey, please complete the Information Request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]

View, Inc. (NASDAQGM: VIEW)

Lifshitz Law Firm, PC announces that a class action lawsuit has been filed against View, alleging that the Defendants failed to disclose to investors: (1) that View did not properly accumulate warranty costs related to its product; (2) that there was a material weakness in View’s internal controls over accounting and financial reporting related to collateral accumulation; (3) that, therefore, the Company’s financial results for previous periods were inaccurate; and (4) as a result, the Defendants’ statements regarding its business, operations and prospects were materially false and misleading and / or lacked reasonable basis at all relevant times.

If you are a View investor and would like additional information about our survey, please complete the Information Request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]

LAWYER ADVERTISING.© 2021 Lifshitz Law Firm, PC The law firm responsible for this announcement is Lifshitz Law Firm, PC, 1190 Broadway, Hewlett, New York 11557, Tel. : (516) 493-9780. Past results do not guarantee or predict a similar result with respect to any future matters.

Contact:

Joshua M. Lifshitz, Esq.
Law firm Lifshitz, CP
Telephone: 516-493-9780
Fax: 516-280-7376
E-mail: [email protected]


Previous Omicron and Covid-19 news: live updates
Next Federal law still treats marijuana as an illegal drug, creating headaches for states